Siegall Clay B

President and CEO, DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Feb 3, 2025
Net Buying
Open-Market Buys
$1.2M
Open-Market Sells
$0
Net Open-Market Flow
$1.2M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2025Buy(P)150K$7.75$1.2M670K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002824) within minutes of acceptance. Every field above traces to the original document. Verify it directly: